In this study, we introduce an approach for synthesizing polydopamine (PDA) through the controlled oxidation of dopamine using metallic copper. Traditional methods of PDA synthesis often encounter challenges such as scalability, reproducibility, and control over polymerization. Our approach utilizes the catalytic properties of metallic copper in the presence of dissolved oxygen to generate reactive oxygen species (ROS) without additional chemicals. This process allows for precise control over dopamine oxidation, leading to reliable, materials and cost-effective upscalable PDA production. We investigated the reaction kinetics and the role of copper and ROS in dopamine oxidation, using several different experimental techniques. Our results demonstrate that, even at low pH, the copper-assisted method produces PDA with properties comparable to those synthesized through conventional means. We propose a mechanism for PDA synthesis that is initiated by oxygen adsorption onto copper surface, leading to the generation of various ROS which act as oxidizing agents in PDA synthesis. This method presents an advancement in the scalable and controlled production of PDA, with potential applications in various scientific and industrial fields.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.langmuir.4c02460DOI Listing

Publication Analysis

Top Keywords

dopamine oxidation
12
pda synthesis
12
metallic copper
8
pda
7
heterogenous copper0-assisted
4
dopamine
4
copper0-assisted dopamine
4
oxidation
4
oxidation pathway
4
pathway controllable
4

Similar Publications

Though nanozymes are becoming promising alternatives to natural enzymes due to their superior properties, constructing nanozyme with high specificity is still a great challenge. Herein, with Cu2+ as an active site and adenine as a ligand, Adenine-Cu-PO4 is synthesized in phosphate-buffered saline. As an oxidase mimic, Adenine-Cu-PO4 could selectively catalyze oxidation of ascorbic acid (AA) to dehydroascorbic acid, but not universal substrates (3,3',5,5'-tetramethylbenzidine (TMB), 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) and 2,4-dichlorophenol (2,4-DP)), small biomolecules (dopamine, glutathione, glucose, galactose), other vitamins (vitamin A acid, vitamin B1, vitamin K1) and even dithiothreitol (a common interference of AA).

View Article and Find Full Text PDF

Continuous compensation for cerebral dopamine deficiency represents an ideal treatment for Parkinson's disease. Dopamine does not cross the digestive and blood-brain barriers and is rapidly oxidized. The new concept is the intracerebroventricular administration of anaerobic dopamine (A-dopamine) using an abdominal pump connected to a subcutaneous catheter implanted in the third ventricle, near the striatum.

View Article and Find Full Text PDF

An ammonium perchlorate (AP) composite system with double-coating encapsulation based on the interfacial polymerization behavior of dopamine (DA) in Pickering emulsions was designed to enhance the combustion performance of HTPB-based propellants. The composite system proved highly effective in mitigating the agglomeration issues associated with iron oxide nanoparticles (FeO NPs) as catalysts, with the AP exhibiting superior performance compared to the composite comprising pure FeO NPs. The results of the thermal decomposition experiments showed that the HTD temperature of AP@PDA@FeO was reduced to 318.

View Article and Find Full Text PDF

G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis.

Cell Rep

January 2025

Department of Molecular and Cellular Biology, The University of Guelph, Guelph ON, Canada; Department of Clinical Neuroscience, University of Calgary, Calgary, AB, Canada. Electronic address:

Loss of dopaminergic neurons in Parkinson's disease (PD) is preceded by loss of synaptic dopamine (DA) and accumulation of proteinaceous aggregates. Linking these deficits is critical to restoring DA signaling in PD. Using murine and human pluripotent stem cell (hPSC) models of PD coupled with human postmortem tissue, we show that accumulation of α-syn micro-aggregates impairs metabolic flux through the pentose phosphate pathway (PPP).

View Article and Find Full Text PDF

Epidemiological studies have linked fine dust pollution to depression, yet the underlying mechanisms remain unclear. Oxidative stress and endoplasmic reticulum (ER) stress are known contributors to depression, but their induction by particulate matter (PM), particularly PM2.5, in animal models has been limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!